Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Nintedanib
Related studies linked through entity extraction aliases.
Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nintedanib in Patients With Advanced Esophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research
- Status
- TERMINATED
- Phase
- PHASE3
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nintedanib in Volunteers With Hepatic Impairment Compared With Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
ENGOT-cx1/BGOG-cx1: 3 Weekly Carboplatin/Paclitaxel With or Without Nintedanib in Cervix Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE3
Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens
- Status
- COMPLETED
- Phase
- PHASE2
Nintedanib (BIBF 1120) in Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Nintedanib(BIBF1120) in Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin
- Status
- COMPLETED
- Phase
- PHASE1
Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Docetaxel +/- Nintedanib in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)
- Status
- COMPLETED
- Phase
- PHASE2